These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1864 related articles for article (PubMed ID: 15032581)

  • 1. The three Es of cancer immunoediting.
    Dunn GP; Old LJ; Schreiber RD
    Annu Rev Immunol; 2004; 22():329-60. PubMed ID: 15032581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibrium.
    Curigliano G; Criscitiello C; Esposito A; Fumagalli L; Gelao L; Locatelli M; Minchella I; Goldhirsch A
    Breast; 2013 Aug; 22 Suppl 2():S96-9. PubMed ID: 24074802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leukocyte antigen-G and cancer immunoediting.
    Urosevic M; Dummer R
    Cancer Res; 2008 Feb; 68(3):627-30. PubMed ID: 18245459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunobiology of cancer immunosurveillance and immunoediting.
    Dunn GP; Old LJ; Schreiber RD
    Immunity; 2004 Aug; 21(2):137-48. PubMed ID: 15308095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer immunoediting: from immunosurveillance to tumor escape.
    Dunn GP; Bruce AT; Ikeda H; Old LJ; Schreiber RD
    Nat Immunol; 2002 Nov; 3(11):991-8. PubMed ID: 12407406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer immunosurveillance and immunoediting by natural killer cells.
    Gross E; Sunwoo JB; Bui JD
    Cancer J; 2013; 19(6):483-9. PubMed ID: 24270347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune approaches to the treatment of breast cancer, around the corner?
    Criscitiello C; Esposito A; Gelao L; Fumagalli L; Locatelli M; Minchella I; Adamoli L; Goldhirsch A; Curigliano G
    Breast Cancer Res; 2014 Feb; 16(1):204. PubMed ID: 25774617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immune system--is it relevant to cancer development, progression and treatment?
    Prestwich RJ; Errington F; Hatfield P; Merrick AE; Ilett EJ; Selby PJ; Melcher AA
    Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):101-12. PubMed ID: 18037277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural innate and adaptive immunity to cancer.
    Vesely MD; Kershaw MH; Schreiber RD; Smyth MJ
    Annu Rev Immunol; 2011; 29():235-71. PubMed ID: 21219185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer immunoediting and "spontaneous" tumor regression.
    Sengupta N; MacFie TS; MacDonald TT; Pennington D; Silver AR
    Pathol Res Pract; 2010 Jan; 206(1):1-8. PubMed ID: 19945228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy.
    Vesely MD; Schreiber RD
    Ann N Y Acad Sci; 2013 May; 1284(1):1-5. PubMed ID: 23651186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Immunoediting: Elimination, Equilibrium, and Immune Escape in Solid Tumors.
    Wilczyński JR; Nowak M
    Exp Suppl; 2022; 113():1-57. PubMed ID: 35165859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor immunoediting and immunosculpting pathways to cancer progression.
    Reiman JM; Kmieciak M; Manjili MH; Knutson KL
    Semin Cancer Biol; 2007 Aug; 17(4):275-87. PubMed ID: 17662614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferons, immunity and cancer immunoediting.
    Dunn GP; Koebel CM; Schreiber RD
    Nat Rev Immunol; 2006 Nov; 6(11):836-48. PubMed ID: 17063185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity.
    Smyth MJ; Dunn GP; Schreiber RD
    Adv Immunol; 2006; 90():1-50. PubMed ID: 16730260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?
    Bui JD; Schreiber RD
    Curr Opin Immunol; 2007 Apr; 19(2):203-8. PubMed ID: 17292599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural immunity to cancer in humans.
    Bindea G; Mlecnik B; Fridman WH; Pagès F; Galon J
    Curr Opin Immunol; 2010 Apr; 22(2):215-22. PubMed ID: 20207124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune surveillance of human cancer: if the cytotoxic T-lymphocytes play the music, does the tumoral system call the tune?
    Hamaï A; Benlalam H; Meslin F; Hasmim M; Carré T; Akalay I; Janji B; Berchem G; Noman MZ; Chouaib S
    Tissue Antigens; 2010 Jan; 75(1):1-8. PubMed ID: 20196816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host immune response in B-cell lymphomas: friend or foe?
    Juszczyński P; Nowak J; Warzocha K
    Arch Immunol Ther Exp (Warsz); 2008; 56(4):245-55. PubMed ID: 18726146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer immunoediting from immune surveillance to immune escape.
    Kim R; Emi M; Tanabe K
    Immunology; 2007 May; 121(1):1-14. PubMed ID: 17386080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 94.